abha@qu-consulting.com
+1-732-858-2299
Home
About
Practices
Open menu
Compliance
Regulatory Affairs
Science And Technology
Blogs
Contact
X
Contact Us
Blog & News
Home
Blog
October 31, 2025
Major regulatory breakthrough: FDA moves to make biologic drugs…
Read More
October 28, 2025
🚀 FDA Opens the Black Box: Filing Checklists Now…
Read More
October 24, 2025
FDA launches new fast-track incentive for national health priorities
Read More
August 25, 2025
FDA Moves to Real-Time Adverse Event Reporting
Read More
August 11, 2025
The FDA has announced FDA PreCheck— a program to boost…
Read More
August 11, 2025
UK Streamlines Regulatory Pathway to Accelerate Market Access by…
Read More
February 18, 2025
Innovative Licensing and Access Pathway
Read More
February 18, 2025
Strategic Agenda for FDA‘s rare disease, innovation hub
Read More
June 8, 2024
505 (b)(2) Application
Read More
December 26, 2023
Narrow Your Focus to Prevent Overanalysis
Read More
December 26, 2023
Stick with Your Concept but Do Your Homework
Read More
December 26, 2023
Three Social Media Hacks for the Busy Entrepreneur
Read More
December 26, 2023
Harvest great ideas from your company’s best assets
Read More
December 26, 2023
Reply to MOH queries
Read More
December 26, 2023
Clinical and non-clinical overviews
Read More
December 26, 2023
Export Dossier Documents
Read More
December 26, 2023
International Regulatory Registration
Read More
December 26, 2023
Pre-submission compilation and checking
Read More
December 26, 2023
Lupin recalls 12,480 bottles of anti-depressant drug from US.
Read More
December 26, 2023
Zydus Cadila launches anti-ulcer drug in US.
Read More
December 26, 2023
To fight China monopoly, Indian Govt to approve for…
Read More
December 26, 2023
The U.S. Food and Drug Administration approved Zurzuvae (zuranolone),…
Read More
December 26, 2023
The U.S. Food and Drug Administration issued a draft…
Read More
December 26, 2023
The U.S. Food and Drug Administration approved Abrysvo (Respiratory…
Read More
December 26, 2023
The U.S. Food and Drug Administration has approved Tyruko…
Read More
December 26, 2023
Bimervax, the COVID-19 vaccine developed by HIPRA Human Health,…
Read More
December 26, 2023
Medicare Drug Price Negotiation Program: Selected Drugs for Initial…
Read More
About Us
26 Harvard Circle, Princeton NJ
+1 609-945-1626
abha@qu-consulting.com
Recent Post
Major regulatory breakthrough: FDA moves to make biologic drugs more affordable
🚀 FDA Opens the Black Box: Filing Checklists Now Public to Reduce Delays
FDA launches new fast-track incentive for national health priorities
Need Help?
Looking for someone who can help you with your Industry decisions ?
Contact Us